EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest
EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 26,800 shares, a decrease of 23.9% from the November 30th total of 35,200 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 1.7 days.
效應器治療, 公司. (NASDAQ: EFTRW — 獲取評級) 是在十二月份短期利益顯著下降的接收者.截至十二月十五日，短期利息共計 26,800 股，較十一月三十日共 35,200 股股份下降 23.9%。以 16,000 股的平均交易量計算，日數佔覆蓋率目前為 1.7 天。
eFFECTOR Therapeutics Price Performance
效應器治療價格性能
NASDAQ EFTRW remained flat at $0.16 on Friday. The company has a fifty day moving average of $0.13 and a 200-day moving average of $0.17. eFFECTOR Therapeutics has a fifty-two week low of $0.04 and a fifty-two week high of $0.99.
納斯達克外匯交易所週五維持在 0.16 美元的水平。該公司的五十天移動平均線為 0.13 美元，200 天移動平均線為 0.17 美元，效應器治療有五十二周低點 0.04 美元，五十二周高點為 0.99 美元。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Is Kintara Therapeutics A Hidden Gem?
- Should You Warm up to Generac Stock for the Winter?
- 獲取有關效應器治療研究報告的免費副本
- 市場節拍：評論中的一周
- 科技的狗：是時候咬一口這些股票了
- 這次收購是否使微軟成為熊市購買？
- 金塔拉治療學是一個隱藏的寶石嗎？
- 你應該熱身 Generac 股票的冬天嗎？
Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收效應器治療的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Effector 治療和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。